Dr Lawrence Okiror is a Consultant Thoracic and Robotic Surgeon at Guy’s and St Thomas’ NHS Foundation Trust and London Bridge Hospital, specialising in lung nodule assessment, early lung cancer, robotic thoracic surgery, and the full spectrum of thoracic surgical conditions. FRCS(CTh) FRCSEd(CTh). GMC 6150382. Private appointments at London Bridge Hospital within 2–3 days. Self-referrals welcome.
Last reviewed: May 2026 · Dr Lawrence Okiror FRCS(CTh) FRCSEd(CTh) · GMC 6150382
Guy’s and St Thomas’ NHS Foundation Trust — the UK’s largest lung cancer centre. Operative survival rate 99.59% vs 98.5% national. 71.3% of anatomic resections performed robotically vs 24% national. Source: SCTS National Audit 2024–25.
London Bridge Hospital — first in Europe for ION bronchoscopy outside trials. The Lister Hospital Chelsea. Outreach: Canary Wharf and City of London. Appointments within 2–3 days. Self-referrals welcome.
153 lung cancer operations in 2024–25. Career total 1,000+. Approximately 1 in every 50 lung cancer operations performed nationally. Over 80% by robotic or keyhole technique. Source: SCTS National Audit 2024–25; personal operative data 2024–25.
Designation
Consultant Thoracic & Robotic Surgeon
FRCS(CTh) · FRCSEd(CTh)
NHS Base
Guy’s and St Thomas’ NHS Foundation Trust
Honorary Appointments
Honorary Consultant Thoracic Surgeon — Queen Elizabeth Hospital Woolwich and Darent Valley Hospital
Private Practice
London Bridge Hospital
The Lister Hospital, Chelsea
Canary Wharf & City of London
Access
Appointments within 2–3 days
Self-referrals welcome
Fees
New consultations from £250
Most major insurers accepted
GMC Registration
6150382
Contact
Jo Mitchelson, Private PA
020 7952 2882
pa@lungsurgeon.co.uk
Patient Reviews
“Most patients who come to me with a lung nodule do not need surgery. My job is to tell them that with confidence — or, where intervention is the right answer, to make sure it is the most precise and least invasive option available.”
Dr Okiror’s NHS base, Guy’s and St Thomas’ NHS Foundation Trust, is the UK’s largest lung cancer centre — and home to the UK’s largest thoracic robotic surgery programme, performing 71.3% of anatomic resections robotically, more than double the national rate of 24%. London Bridge Hospital, where he sees private patients, was the first centre in Europe to offer robotic ION bronchoscopy in routine clinical practice outside NHS trials. Both institutions are ranked in the top ten UK hospitals by Newsweek World’s Best Hospitals 2026, assessed independently across 32 countries.
Within this framework, Dr Okiror performed 153 lung cancer operations in 2024–25 — over 1,000 as a consultant. He personally accounts for approximately 1.94% of all lung cancer surgery in the UK — around one in every 50 operations performed nationally. His operative survival rate is 99.59% against a national benchmark of 98.5%. More than 80% of operations are performed by robotic or minimally invasive technique. Source: SCTS National Thoracic Surgery Audit 2024–25; personal operative data 2024–25.
His private practice is built around lung nodule assessment and early lung cancer decision-making: consultant-led diagnosis with clear next steps from the first appointment. Where investigation or surgery is needed, he offers robotic bronchoscopy (ION) and minimally invasive robotic surgery at London Bridge Hospital. He also leads the nationally commissioned Advanced Emphysema Surgical Service at GSTT — the sole endobronchial valve and lung volume reduction surgery operator at GSTT and London Bridge Hospital — with a monthly specialist MDT that uniquely includes the Harefield lung transplant team.
Dr Okiror sits in approximately 180 lung MDTs per year across the south-east regional network — three weekly NHS lung MDTs at Guy’s and St Thomas’, Queen Elizabeth Hospital Woolwich, and Darent Valley Hospital (where he holds honorary consultant thoracic surgeon appointments), together with a fortnightly private-sector lung MDT and the monthly GSTT emphysema MDT joined by the Harefield lung transplant team. He chairs ad hoc complex-case MDTs at GSTT, including joint discussions with the ECMO team, and provides cross-specialty thoracic surgical input to the Lane Fox respiratory failure service, adult congenital heart disease (ACHD), and ENT and head and neck teams.
Beyond his clinical work, Dr Okiror holds active examining and standard-setting appointments across the UK and Europe: member of the Surgical Specialty Board in Cardiothoracic Surgery at the Royal College of Surgeons of Edinburgh, nominated by the Board as its representative to the College’s Robotic Surgery Taskforce; examiner for both the UK Intercollegiate Board and the European Board of Cardiothoracic Surgery; and Block Lead at King’s College London Medical School. He has published over 30 peer-reviewed papers and four book chapters in reference thoracic surgical textbooks. He is Lead Surgeon at GSTT for the NIHR-funded MIST-4 trial (ISRCTN16328099) and PRO-SEAL (ISRCTN15099654).
Guy’s and St Thomas’ NHS Foundation Trust
NHS consultant at a centre performing approximately 12% of all lung cancer surgery in the UK. Operative survival rate 99.59% vs national average 98.5%. 71.3% of anatomic resections performed robotically — more than double the national rate of 24%. Only 6% wedge resections versus 14% nationally.
Leads the Central Airways Service and the nationally commissioned Advanced Emphysema Surgical Service — sole operator for endobronchial valve therapy and lung volume reduction surgery at GSTT and London Bridge Hospital.
Source: SCTS National Thoracic Surgery Audit 2024–25
London Bridge Hospital & The Lister Chelsea
Private practice covering lung nodule assessment, early lung cancer, robotic and VATS thoracic surgery, ION bronchoscopy, emphysema, pleural disease, pneumothorax, hyperhidrosis (ETS), thoracic outlet syndrome, diaphragm conditions, and mediastinal tumours.
Outreach clinics at Canary Wharf and City of London. Appointments within 2–3 days. Self-referrals welcome.
Guy’s and St Thomas’ NHS Foundation Trust
Leads clinical governance and outcome audit for the thoracic surgery department, benchmarking results against national standards. Leads the monthly clinical audit of the GSTT navigational bronchoscopy programme — approximately 635 procedures per year and one of the UK’s busiest ION bronchoscopy services.
Also leads the monthly Advanced Emphysema MDT, which uniquely includes a lung transplantation physician and surgeon from Harefield Hospital.
Dr Okiror holds active examining and standard-setting appointments across the UK and Europe — not honorary roles. He helps determine what constitutes excellence in thoracic surgery training and practice at national and European level. When you see Dr Okiror privately, you are seeing one of the surgeons who sets the examination standard against which all cardiothoracic surgeons in the UK and Europe are assessed.
Surgical Specialty Board in Cardiothoracic Surgery, Royal College of Surgeons of Edinburgh
Member since January 2022; term extended and currently active. Nominated by the Board as its representative to the College’s Robotic Surgery Taskforce.
Chair — “Lung Volume Reduction” session, SCTS Annual Meeting 2026
Tuesday 17 March 2026, ICC Belfast. Society for Cardiothoracic Surgery in Great Britain and Ireland.
RCSEd Education Webinar — Robotics in Thoracic Surgery
Convened and chaired the College’s educational webinar on robotic thoracic surgery (12 July 2022). Featured in the College’s Robot Assisted Surgery podcast series (listen here).
Examiner — UK Intercollegiate Board in Cardiothoracic Surgery
Active examiner for the UK exit examination in cardiothoracic surgery.
Examiner — European Board of Cardiothoracic Surgery
Sets and assesses the standard for cardiothoracic surgical practice at European level.
Block Lead — King’s College London Medical School
Leads an undergraduate teaching block in thoracic and surgical medicine.
Dr Okiror’s research is focused on minimally invasive lung cancer surgery, robotic surgical technique, outcome optimisation, and advanced emphysema therapies — the same areas at the centre of his clinical practice.
30+
Peer-reviewed
publications
MIST-4
Lead Surgeon, GSTT
ISRCTN16328099
PRO-SEAL
Lead Surgeon, GSTT
ISRCTN15099654
4
Authored book
chapters
Authored Book Chapters — Reference Textbooks in Thoracic Surgery
Recent peer-reviewed contribution
Toki S, Bille A, Okiror L, et al. Real-world outcomes of locally advanced non-small cell lung cancer at a high-volume UK centre. Lung Cancer 2025;200:108200. Co-authored from the Guy’s and St Thomas’ series.
Dr Okiror is independently verified on Doctify — the UK’s leading platform for specialist healthcare reviews. 19 verified five-star reviews.
Primary Private Hospital
27 Tooley Street, London SE1 2PR. Dr Okiror’s primary private base for consultations and surgery — robotic and VATS procedures, ION bronchoscopy, and lung resection. Appointments within 2–3 days.
Newsweek World’s Best Hospitals 2026: #10 UK — UK’s highest-ranked private hospital.
Second Private Hospital
Chelsea Bridge Road, London SW1W 8RH. Consultations and selected procedures at The Lister, serving patients in Chelsea, Kensington, and surrounding areas. Appointments within 2–3 days.
Part of HCA Healthcare UK.
Outreach Clinics
Consultation clinics at Canary Wharf and the City of London. Contact Jo on 020 7952 2882 for availability.
Questions patients and referring clinicians most commonly ask about Dr Okiror’s practice and how to access it.
Book a Consultation →Or call Jo Mitchelson:
020 7952 2882
Dr Okiror accepts a limited number of new private patients. Most are seen within 2–3 days at London Bridge Hospital or The Lister Chelsea. Self-referrals welcome. New consultations from £250. Most major insurers accepted.
Jo Mitchelson, Private PA · 020 7952 2882 · pa@lungsurgeon.co.uk
Guy’s and St Thomas’ ranked #1 and #2 in the UK · London Bridge Hospital #10 · Newsweek World’s Best Hospitals 2026, independently assessed across 32 countries.